🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide SYNCHRONIZE Phase 3 — November 2025 Page 3

Survodutide SYNCHRONIZE Phase 3 — November 2025

ZaraB_AL Thu, Sep 12, 2024 at 4:18 AM 56 replies 2,243 viewsPage 3 of 12
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Sep 15, 2024 at 10:47 AM#11
DebRD_ATL said:
Relative and absolute effects need reading together.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

Correct me if the detail matters more than I have assumed.

4 2EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 1 other
Reply Quote Save Share Report
DoseLogDan
Member
201
567
Feb 2025
Montana
Sep 17, 2024 at 2:20 AM#12
AussieAnna said:
Agreed, and subgroup analyses deserve particular suspicion.

That reframing is the part I needed. Adding it to my notes with a link back to this thread.

5 3Dr.AddMedPHL, newstart_MO, mia_MS2 and 2 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Sep 18, 2024 at 5:52 PM#13
DebRD_ATL said:
Relative and absolute effects need reading together.

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

Worth separating that from the trial evidence, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

6 4RunnerRach, TrialNerd_Beth, HPLC_Greg and 3 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Sep 20, 2024 at 9:23 AM#14

One concrete data point for the thread. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

Last edited: Sep 20, 2024 at 3:23 PM
7 5SaraMom3, Dr.MetabolicMD, RetaRick_CA and 4 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Sep 22, 2024 at 12:53 AM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Report rather than reply if it drifts again.

8 6PurityPaulOR, MaxMetOK, MounjBrad and 5 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register